Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Xu, Yi ^a   Armstrong, Stephen J ^a   Arenas, Ivan A ^a   Pehowich, Daniel J ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aging; Ischemia; Oxygen radicals; Reperfusion

Indexed keywords

ESTROGEN; GLYCOPROTEIN GP 91; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SALEN CHLORIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; PROTEIN P22; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MIMETIC AGENT; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FUNCTIONAL ASSESSMENT; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HORMONE SUBSTITUTION; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK ASSESSMENT;

AGING; ANIMALS; BODY WEIGHT; CARDIOTONIC AGENTS; ESTROGENS; ETHYLENEDIAMINES; FEMALE; HEART; HEART VENTRICLES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; ORGANOMETALLIC COMPOUNDS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SUPEROXIDE DISMUTASE; TYROSINE; UTERUS;

EID: 3042531049     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00037.2004     Document Type: Article

References (40)

1. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, and Colucci WS. Reactive oxygen species mediate α-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 131-139, 2001.
2. Anonymous. Role of progesterogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause 10: 113-132, 2003.
3. Armstrong SJ, Zhang Y, Stewart KG, and Davidge ST. Estrogen replacement reduces PGHS-2-dependent vasoconstriction in the aged rat. Am J Physiol Heart Circ Physiol 283: H893-H898, 2002.
4. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, and Doctrow SR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 284: 215-221, 1998.
5. Beer S, Reincke M, Kral M, Lie SZ, Steinhauer S, Schmidt HH, Allolio B, and Neubauer S. Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. J Cardiovasc Pharmacol 40: 420-428, 2002.
6. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897-1918, 2001.
7. Cheung PY, Danial H, Jong J, and Schulz R. Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys 350: 104-108, 1998.
8. Drew B and Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann NY Acad Sci 959: 66-81, 2002.
9. 2+-independent nitric oxide synthase by 17β-estradiol in post-ischemic rat heart. Cardiovasc Res 46: 111-118, 2000.
10. Gragasin FS, Xu Y, Arenas IA, Kainth N, and Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38-44, 2003.
11. Hayashi Y, Sawa Y, Ohtake S, Fukuyama N, Nakazawa H, and Matsuda H. Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation. Ann Thorac Surg 72: 571-576, 2001.
12. Hernandez I, Delgado JL, Diaz J, Quesada T, Teruel MJ, Llanos MC, and Carbonell LF. 17β-Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 279: R1599-R1605, 2000.
13. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613, 1998.
14. Lee WH, Gounarides JS, Roos ES, and Wolin MS. Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model. Am J Physiol Heart Circ Physiol 285: H1385-H1395, 2003.
15. Lemay A. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 24: 711-715, 2002.
16. Lesnefsky EJ, Gallo DS, Ye J, Whittingham TS, and Lust WD. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med 124: 843-851, 1994.
17. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, and French BA. Gene therapy with extracellutar superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 103: 1893-1898, 2001.
18. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, Wu WJ, Zhu Y, and Bolli R. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res 92: 741-748, 2003.
19. Liu P, Hock CE, Nagele R, and Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol Heart Circ Physiol 272: H2327-H2336, 1997.
20. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, and Cushman M. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523-534, 2003.
21. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
22. 2+/ calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol Cell Physiol 277: C384-C391, 1999.
23. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, and Hori M. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17β-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation 96: 1953-1963, 1997.
24. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Miyamoto K, Nishiwaki H, Mandai M, Honda Y, and Ogura Y. Administration of 17β-estradiol attenuates retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 41: 2689-2696, 2000.
25. Pinsky JL, Jette AM, Branch LG, Kannel WB, and Feinleib M. The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health 80: 1363-1367, 1990.
26. Pucheu S, Boucher F, Sulpice T, Tresallet N, Bonhomme Y, Malfroy B, and de Leiris J. EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated iron-overloaded rat heart from functional and structural damage induced by ischemia/reperfusion. Cardiovasc Drugs Ther 10: 331-339, 1996.
27. Sharpe MA, Ollosson R, Stewart VC, and Clark JB. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 366: 97-107, 2002.
28. Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG, and Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 104: 2300-2304, 2001.
29. Song X, Li G, Vaage J, and Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 177: 459-466, 2003.
30. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, and Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93: 170-177, 2003.
31. Stupka N and Tiidus PM. Effects of ovariectomy and estrogen on ischemia-reperfusion injury in hindlimbs of female rats. J Appl Physiol 91: 1828-1835, 2001.
32. Tanguy S, Boucher FR, Malfroy B, and de Leiris JG. Free radicals in reperfusion-induced arrhythmias: study with EUK 8, a novel nonprotein catalytic antioxidant. Free Radic Biol Med 21: 945-954, 1996.
33. Wang W, Sawicki G, and Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 53: 165-174, 2002.
34. Wenger NK. Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 53: 558-567, 2002.
35. Wolf G, Hannken T, Schroeder R, Zahner G, Ziyadeh FN, and Stahl RA. Antioxidant treatment induces transcription and expression of transforming growth factor-β in cultured renal proximal tubular cells. FEBS Lett 488: 154-159, 2001.
36. Xu Y, Arenas IA, Armstrong SJ, and Davidge ST. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 57: 388-394, 2003.
37. Xu Y, Clanachan AS, and Jugdatt BI. Enhanced expression of angiotensin II type 2 receptor, inositol 1,4,5-trisphosphate receptor, and protein kinase C-ε during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension 36: 506-510, 2000.
38. 2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol 282: H1206-H1215, 2002.
39. Yasmin W, Strynadka KD, and Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33: 422-432, 1997.
40. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, and Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279: H2766-H2775, 2000.